IO Biotech, Inc. Banner Image

IO Biotech, Inc.

  • Ticker IOBT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
IO Biotech, Inc. Logo Image
  • 51-200 Employees
  • Based in Copenhagen, Denmark
IO Biotech is a clinical-stage biopharmaceutical company pioneering the first-in-class investigational dual-action immune-modulating cancer vaccine with the goal of becoming the backbone of combination therapy for people with cancer. The Company’s T-win® vaccine platform is directed against the tumor microenvironment (TME) and is designed to stimulate T cells against tumor cells and theMore most important immune-suppressive cells in the TME. IO Biotech’s most advanced program for IO102-IO103 is currently in Phase 3 development. IO Biotech is headquartered in Copenhagen, Denmark.
4.0 / 5.0 (1)

IO Biotech, Inc. reports have an aggregate usefulness score of 4.0 based on 1 reviews.

IO Biotech, Inc.

Most Recent Annual Report

IO Biotech, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

IO Biotech, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!